Vés al contingut

A randomized, double-blind, placebo-controlled, parallelgroup,Proof-of-Concept (PoC) study to assess theefficacy,safety and tolerability of itepekimab in participants with non-cystic fibrosis bronchiectasis

Obert
  • Codi protocol: ACT18018
  • Codi EudraCT: No aplica
  • Grup de recerca: Pneumologia
  • Servei: Pneumologia
  • Investigador/a principal:  Polverino , Eva
  • Malaltia: Malalties del sistema respiratori
  • Fase: Fase I
  • Estat: Reclutant voluntaris